Clinical Trials Browser

Phase 1 × INDUSTRY × Myeloid Malignancy × Clear all

NCT07619287 2026-06-01

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies

Phase 1 Not yet recruiting

Myeloid Malignancy

NCT04214860 2025-03-17

APR-246 in Combination With Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies

Phase 1 Completed

51 enrolled 9 charts

Myeloid Malignancy